Skip to main content
SpringerLink
Log in

Are There Risk Factors in the European Population, Which Promote Rectal Cancer and/or Favour Curability?

  • Chapter
  • First Online:
Multidisciplinary Management of Rectal Cancer

Abstract

Although the survival of rectal cancer has steadily improved in recent years [1], differences in the distribution of cases by stage at diagnosis and in survival within each stage strongly indicate that there are opportunities to improve outcomes if we are able to apply that what we know is effective. Challenges posed by the ageing of the population and its impact on the comorbidity at diagnosis are factors with strong influence on the therapeutic decision-making. Rectal cancer is also associated with hereditary syndromes that could modify significantly the therapeutic approach and, as a consequence, patients’ prognosis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  1. Brenner H, Bouvier A, Foschi V et al (2012) Progress in colorectal cancer survival in Europe from the late 1980s to the early 21st century: the EUROCARE study. Int J Cancer 131:1649–1658

    Article  CAS  PubMed  Google Scholar 

  2. Maringe C, Walters S, Rachet B et al (2013) Stage at diagnosis and colorectal cancer survival in six high-income countries: a population-based study of patients diagnosed during 2000-2007. Acta Oncol 52:919–932

    Article  PubMed  Google Scholar 

  3. Liu L, Lemmens V, de Hingh IH et al (2013) Second primary cancers in subsites of colon and rectum in patients with previous colorectal cancer. Dis Colon Rectum 56:158–163

    Article  PubMed  Google Scholar 

  4. Continuous Update Project (2011) Colorectal cancer report, 2011: food, nutrition, physical activity and the prevention of colorectal cancer. World Cancer Research Fund/American Institute for Cancer Research, Washington

    Google Scholar 

  5. Romaguera D, Ward H, Wark P et al (2015) Pre-diagnostic concordance with the WCRF/AICR guidelines and survival in European colorectal cancer patients. BMC Med 13:107

    Article  PubMed  PubMed Central  Google Scholar 

  6. Chan AT, Arber N, Burn J et al (2012) Aspirin in the chemoprevention of colorectal neoplasia: an overview. Cancer Prev Res 5:164–178

    Article  CAS  Google Scholar 

  7. Lemmens VEPP, Jansen-Heijnen MLG, Verweij CDGW et al (2005) Co-morbidity leads to altered treatment and worse survival of elderly patients with colorectal cancer. Br J Surg 92:615–623

    Article  CAS  PubMed  Google Scholar 

  8. von Karsa L, Patnik J, Segnan N et al (2013) European guidelines for quality assurance in colorectal cancer screening and diagnosis: overview and introduction to the full supplement publication. Endoscopy 45:51–59

    Article  Google Scholar 

  9. Brenner H, Hoffmeister M, Arndt V et al (2010) Protection from right and left-hand sided colorectal neoplasms after colonoscopy: population based study. Ann Intern Med 102:89–95

    Google Scholar 

  10. Vasen HF, Tomlinson I, Castells A (2015) Clinical management of hereditary colorectal cancer syndromes. Nat Rev Gastroenterol Hepatol 12:88–97

    Article  PubMed  Google Scholar 

  11. Moreira L, Pellise M, Carballal S et al (2013) High prevalence of serrated polyposis syndrome in FIT-based colorectal cancer screening programmes. Gut 62:476–477

    Article  PubMed  Google Scholar 

  12. de la Chapelle A (2005) The incidence of lynch syndrome. Familial Cancer 4:233–237

    Article  PubMed  Google Scholar 

  13. Lee JS, Petrelli NJ, Rodriguez-Bigas MA (2001) Rectal cancer in hereditary nonpolyposis colorectal cancer. Am J Surg 181:207–210

    Article  CAS  PubMed  Google Scholar 

  14. Vasen HF, Wijnen JT, Menko FH et al (1996) Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology 110:1020–1027

    Article  CAS  PubMed  Google Scholar 

  15. Maeda T, Cannom RR, Beart RW Jr, Etzioni DA (2010) Decision model of segmental compared with total abdominal colectomy for colon cancer in hereditary nonpolyposis colorectal cancer. J Clin Oncol 28:1175–1180

    Article  PubMed  Google Scholar 

  16. Rodriguez-Bigas MA, Vasen HF, Pekka-Mecklin J et al (1997) Rectal cancer risk in hereditary nonpolyposis colorectal cancer after abdominal colectomy. International collaborative group on HNPCC. Ann Surg 225:202–207

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Jover R, Nguyen TP, Perez-Carbonell L et al (2011) 5-fluorouracil adjuvant chemotherapy does not increase survival in patients with CpG island methylator phenotype colorectal cancer. Gastroenterology 140:1174–1181

    Article  CAS  PubMed  Google Scholar 

  18. Alm T (1975) Surgical treatment of hereditary adenomatosis of the colon and rectum in Sweden during the last 20 years. Part I. Introduction. Surgical procedures used. Pre-and postoperative measures. Arrangement of follow-up. Propositi group, primary and late results. Acta Chir Scand 141:218–227

    CAS  PubMed  Google Scholar 

  19. Koskenvuo L, Mustonen H, Renkonen-Sinisalo L, Jarvinen HJ, Lepisto A (2014) Comparison of proctocolectomy and ileal pouch-anal anastomosis to colectomy and ileorectal anastomosis in familial adenomatous polyposis. Familial Cancer 14:221–227

    Article  Google Scholar 

  20. Castells A, Giardiello FM (2013) Familial colorectal cancer screening: so close, so far. Gastroenterology 144:492–494

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Sciences, IDIBELL, University of Barcelona, Barcelona, Spain

    Josep M. Borras

  2. Department of Research, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands

    Amanda C. R. K. Bos

  3. Department of Gastroenterology, Hospital Clinic, IDIBAPS, CIBERehd, University of Barcelona, Barcelona, Spain

    Antoni Castells

Authors
  1. Josep M. Borras
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Amanda C. R. K. Bos
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Antoni Castells
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Josep M. Borras .

Editor information

Editors and Affiliations

  1. Dept. of Radiation Oncology, UniversitĂ  Cattolica S Cuore, Rome, Italy

    Vincenzo Valentini

  2. Head, Div. Clinical Oncology Research, University Clinic Halle (Saale), Martin-Luther-University Halle-Wittenberg, Halle, Sachsen-Anhalt, Germany

    Hans-Joachim Schmoll

  3. Department of Surgery, Leiden Univ Med Ctr, Leiden, The Netherlands

    Cornelis J. H. van de Velde

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer-Verlag Berlin Heidelberg

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Borras, J.M., Bos, A.C.R.K., Castells, A. (2018). Are There Risk Factors in the European Population, Which Promote Rectal Cancer and/or Favour Curability?. In: Valentini, V., Schmoll, HJ., van de Velde, C. (eds) Multidisciplinary Management of Rectal Cancer. Springer, Cham. https://doi.org/10.1007/978-3-319-43217-5_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-43217-5_4

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-43215-1

  • Online ISBN: 978-3-319-43217-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation